Seoul Pharma Co., Ltd (KOSDAQ:018680)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,315.00
+5.00 (0.15%)
At close: Aug 22, 2025, 3:30 PM KST
0.15%
Market Cap38.30B
Revenue (ttm)52.20B
Net Income (ttm)-660.90M
Shares Out11.66M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,999
Average Volume9,011
Open3,330.00
Previous Close3,310.00
Day's Range3,285.00 - 3,330.00
52-Week Range2,970.00 - 4,730.00
Beta0.59
RSI42.51
Earnings Daten/a

About Seoul Pharma

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and m... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 172
Stock Exchange KOSDAQ
Ticker Symbol 018680
Full Company Profile

Financial Performance

In 2024, Seoul Pharma's revenue was 53.58 billion, an increase of 2.14% compared to the previous year's 52.46 billion. Earnings were 1.70 billion, a decrease of -51.71%.

Financial Statements

News

There is no news available yet.